baber/WOPTO huggingface dataset:
Patent DE-59903640-D1 (DE)
Inventor: SECKELMANN HERBERT
IPC: A47G25/28
Filed: 1999-10-05
Granted: 2003-01-16
Abstract: Mold slides shape the hanger (21) external contour, at the outer ends. They extend to the terminal ends (24) of each arm (22). Preferred Features: A core (12a) forms an undercut in the outer ends of the arm. This is detachable when the mold is opened and its sides are retracted. The slides form a skirt hook incision (23) in the upper sides of each arm (at least). There are two slides for each arm, which are guided in recesses (13) made into the mold parts (11,12).
Patent DE-59904824-D1 (DE)
Inventor: FINKE ANDREAS
IPC: E05D7/10
Filed: 1999-02-08
Granted: 2003-05-08
Abstract: A hinged connection between a removable housing closure and a stationary housing part, wherein a terminal configuration of the housing closure has a convex molding, with a web that is contiguous with the molding and which web has a tapering cross section. Adjacent to the web there is an indentation, in which a convex molding that is on the stationary housing part and is offset at an angle of 90 degrees from a projecting leg and is connected to the projecting leg by a contiguous web that has a tapering cross section is engaged. The housing closure can thereby be pivoted with respect to the stationary housing part and re-engaged with it. Additionally, when the housing is closed, no parts project either inside or outside in the vicinity of the housing closure and the stationary housing part.
Patent DE-59912150-D1 (DE)
Inventor: PETERSEN HOLGER
IPC: H04M1/20
Filed: 1999-09-07
Granted: 2005-07-14
Abstract: The acoustic reflection suppression device has a channel (17) which is sealed with respect to the interior of the telephone handset, used for connecting the volume on the rear side of the hearing capsule (16) with the outside of the telephone handpiece at a point which is spaced from the ear of the user.
Patent DE-60001194-D1 (DE)
Inventor: MARCHESINI VAINER
IPC: B01F15/00
Filed: 2000-02-08
Granted: 2003-02-20
Abstract: A mixer (1) for mixing loose powder, granular and liquid materials, comprises a mixing chamber (8) internally of which a shaft (4) rotates. The shaft (4) bears a plurality of radial blades (13) for agitating the materials. The mixing chamber (8) is provided with an inlet (10) for a liquid. Upstream of the mixing chamber (8) is a batching chamber (6) for a loose material. Each blade (13) comprises a first part which extends lengthwise radially, and a second part, situated at a predetermined radial distance from the shaft (4), which extends lengthwise axially. The mixer produces a high degree of homogenization of components in a resulting mixture, with a relatively low degree of energy consumption. <IMAGE>
Patent DE-60003346-D1 (DE)
Inventor: HAUGAARD JESPER
IPC: C07B61/00
Filed: 2000-01-11
Granted: 2003-07-24
Abstract: A process for the production of a DME/methanol product mixture rich in DME from a make-up stream of an essentially stoichiometrically balanced synthesis gas comprising H2/CO/CO2, comprising the process steps of:   (a) passing a stream of synthesis gas through a cooled reactor containing a catalyst active in methanol formation from synthesis gas, forming a effluent stream enriched in methanol; (b) bringing the effluent from step (a) in contact with a catalyst active in dehydration of methanol, forming a synthesis gas stream further enriched in DME; (c) withdrawing the enriched synthesis gas stream from step (b) and separating the stream into a DME/methanol product mixture rich in DME and a partly converted synthesis gas stream; and (d) recycling a predetermined amount of the partly converted synthesis gas stream to the make-up stream of synthesis gas, forming the synthesis gas stream of step (a).   <IMAGE>
Patent DE-60005208-D1 (DE)
Inventor: CAMPI EDOARDO MARIA
IPC: B65D81/38
Filed: 2000-05-22
Granted: 2003-10-16
Abstract: A container for the thermostatic preservation of liquids, to be used particularly for leisure, sport and for infants, including a shell (8), formed by two coupled portions (9, 10), and forming a cavity (11) for accommodating a vessel (12) which contains the liquid. The shell is made of thermally insulating and impact-resistant material. The invention fully solves the problems of conventional containers, since it achieves a thermostatic preservation of liquids whose duration can be compared to that of thermos flasks and at the same time protects the vessel against any external aggressive agents, such as dust, insects and so forth.
Patent DE-60006948-D1 (DE)
Inventor: ANDERSSON GORAN
IPC: A61P19/10
Filed: 2000-04-07
Granted: 2004-01-15
Abstract: This invention relates to estrogen receptors and bone. In particular the invention relates to an osteoporosis treatment or prevention composition comprising or consisting of an ER beta -selective antagonist.
Patent DE-60012511-D1 (DE)
Inventor: STUELPNAGEL R
IPC: B01L3/00
Filed: 2000-05-22
Granted: 2004-09-02
Abstract: In accordance with the objects outlined above, the present invention provides microfluidic devices for the detection of a target analyte in a sample. The devices comprise a solid support that has any number of modules, including a a sample inlet port and at least one sample handling well comprising a well inlet port and a well outlet port. The device generally further comprises a first microchannel to allow fluid contact between the sample inlet port and the sample handling well. The device also comprises a detection module comprising a substrate with a surface comprising discrete sites, and a population of microspheres comprising at least a first and a second subpopulation, wherein each subpopulation comprises a bioactive agent. The microspheres are distributed on said surface. The detection module also comprises a detection inlet port to receive the sample. The device also comprises a second microchannel to allow fluid contact between the sample handling well and the detection inlet port.
Patent DE-60017165-D1 (DE)
Inventor: SMOLIAROV BORIS V
IPC: A61M5/315
Filed: 2000-10-10
Granted: 2005-02-03
Abstract: Disclosed is a medical device used to prevent the cross contamination of patients or injectors.
Patent DE-60018161-D1 (DE)
Inventor: NING LUPING L
IPC: A23L1/164
Filed: 2000-10-13
Granted: 2005-03-24
Abstract: A breakfast cereal composition for human consumption is provided that comprises at least one cereal grain and a soy material selected from soy flour, soy grits, soy flakes, a comminuted whole soybean material, or combinations thereof. The soy material comprises at most 20  mu mol/g raffinose and 35  mu mol/g stachyose, and at least 200 mu mol/g sucrose. A process for producing the breakfast cereal composition is also provided in which at least one cereal grain and a soy material selected from a soy flour, soy grits, soy flakes, a comminuted whole soybean material, or combinations thereof are blended, cooked to form a cereal dough, and a ready-to-eat cereal composition is formed from the cereal dough. The soy material comprises at most 20  mu mol/g raffinose and 35  mu mol/g stachyose, and at least 200  mu mol/g sucrose. The use of a soy material in reducing coronary heart disease risk in a human is also provided, in which a medicament for human administration is in the form of a cereal composition and comprises the soy material, and the soy material comprises at most 20  mu mol/g raffinose and 35  mu mol/g stachyose, and at least 200  mu mol/g sucrose.
Patent DE-60019654-D1 (DE)
Inventor: HUBSCHEN ALFRED
IPC: B62B5/00
Filed: 2000-01-28
Granted: 2005-06-02
Abstract: The trolley assembly comprises of a loading bed (2) to which are attached two pairs of leg assemblies (4A,4B)that are mounted to the bed assembly in a pivoting manner. The legs can be adjusted in height according to the vehicle in use. The legs are configured in a way such that the they collapse automatically when the trolley is advanced into the cargo bay.
Patent DE-60023143-D1 (DE)
Inventor: SMITH SCOTT
IPC: A61F2/06
Filed: 2000-06-23
Granted: 2005-11-17
Abstract: The present invention relates to a support structure/membrane composite device which includes a support structure, such as a radially expandable stent, a porous non-textile polymeric membrane adjacent to said stent and a thermoplastic anchor means attaching said stent to said porous non-textile polymeric membrane. The porous non-textile polymeric membrane is preferably made from expandable fluoropolymer materials. The anchoring means is a thermoplastic material which is dissolvable at the interface between the support structure and membrane by a suitable solvent which wets the membrane surface and deposits the thermoplastic material within the pores of the membrane. Methods of preparing the device are also disclosed.
Patent DE-60028563-D1 (DE)
Inventor: GAUDREAULT C
IPC: A61P35/00
Filed: 2000-04-12
Granted: 2006-07-20
Abstract: Described herein are novel 1-aryl-3-(2-chloroalkanylureas derivatives. These derivatives are useful anticaner agents having excellent specifilty towards cell targets and potent antineoplastic activity without systemic toxicity derivatives mutagenicity. More specifically, the invention is directed to novel derivatives of the following formula:whereinR1 is C1-C6 alkyl, C3-C7 cycloalkyl, C1-C6 alkoxy, C1-C6 hydroxy alkyl, or C1-C6 halide;R2 is H, C1-C6 alky, C3-C7 cycloalkyl, C1-C6 I alkoxy, C1-C6 hydroxy alkyl or C1-C6 halide, di-halide or tri-halide; R1 and R2 may also be part of cyclic structures.R3 and R4 are as defined in R6 or, halide, di-halide, tri-halide, C1-C7 lower dialkyl, or alicyclic groups fused to the phenyl ring, these alicyclic ring can be substituted by one or more groups as defined in R6;or polycyclic rings bearing not more than three rings wherein the rings other than the ring bearing the substituted 2-chloroethylamino moiety can be substituted by one or more groups as defined in R6;R6 is H, C1-C7 alkyl, C1-C7 alkoxy alkyl, C1-C7 amino alkyl, C1-C6 thio alkyl, C1-C5 S-alkyl, C1-C7 N-alkyl, C1-C7 N,N-dialkyl, C1-C7 cyanoalkyl, C1-C7 haloalkyl, C1-C7 sulfoxide or C3-C7 cycloalkyl; or a prodrug thereofAlso disclosed are pharmaceutical compositions containing the compounds of the invention in conjunction with a pharmaceutically acceptable carrier and the use of the compositions in treating cancer.
Patent DE-60031708-D1 (DE)
Inventor: ANDERSON GORDON
IPC: C07D493/10
Filed: 2000-06-13
Granted: 2006-12-14
Abstract: The rate of aminolysis of butyrolactones is predictably adjusted by attaching a substituent having a known field effect value (F) to the alpha position before reacting the substituted buytrolactone with an amine. The aminolysis product is a gamma-hydroxy amide. The resulting materials are useful as the cross-linking agents in a variety of coatings and coatings processes.
Patent DE-60034382-D1 (DE)
Inventor: BROSTEN DAVID JON
IPC: B01J8/24
Filed: 2000-02-18
Granted: 2007-05-24
Abstract: Process of transferring particulate solids out of a fluidized bed having a bulk density in the range of 0.32 0.64 g/cm<3> via a standpipe, protruding into said fluidized bed through the bottom wall of said fluidized bed, wherein the inlet of said standpipe for receiving particulate solids from the fluidized bed is located close to said bottom wall at a position where the local density is above 0.64 g/cm<3>.
Patent DE-60036452-D1 (DE)
Inventor: SOMA GEN-ICHIRO
IPC: C07K16/44
Filed: 2000-10-18
Granted: 2007-10-31
Abstract: A monoclonal antibody which reacts strongly with uracil and thymine but scarcely with N-carbamyl- beta -alanine; a hybridoma producing this monoclonal antibody; a method of immunochemically assaying uracil or thymine characterized by using the above-described monoclonal antibody; and diagnostics for DPD deficiency containing the above monoclonal antibody. Because of high sensitivity and specific reaction with uracil and thymine, the above-described monoclonal antibody enables convenient, quick, and selective assaying of uracil and thymine in a sample. The antibody is useful in screening patients with DPD deficient cancer with contraindication to the administration of pyrimidine fluoride-based antitumor agents.
Patent DE-60036466-D1 (DE)
Inventor: MOULY MICHEL
IPC: H04W48/10
Filed: 2000-04-05
Granted: 2007-10-31
Abstract: A radiocommunication infrastructure includes a core network comprising switches and subscriber management means and an access network comprising a plurality of base stations capable of communicating by radio with the mobile stations and base station control means. Messages pertaining to services of an idle mode type are: broadcast by one or more of the base stations to be received by mobile stations in idle mode; and/or transmitted by the base station towards at least one mobile station in active mode, for which the base station control means store radio link management information, if said management information includes references relating to the services to which the service messages pertain. These references are received by the control means during a setup procedure which has caused the mobile station to enter the active mode.
Patent DE-60040139-D1 (DE)
Inventor: RITCHIE LAWRENCE
IPC: G01N21/55
Filed: 2000-03-27
Granted: 2008-10-16
Abstract: Liquid, particularly leaked oil or other hydrophobic liquid, is detected by a sensor. This preferably has a hydrophobic membrane (G) that takes up the oil selectively, a radiation source (A) that beams radiation at an interface between the membrane (G) and a window (F), and a radiation detector (H) that receives radiation resulting from interaction (such as reflection, scattering or fluorescence) of the input radiation with the liquid-containing membrane (G). The detector may employ a spectrofluorimeter (H) whose output can be used to characterise the liquid.
Patent DE-60100573-D1 (DE)
Inventor: GRESSIER CHRISTOPHE
IPC: B65D90/10
Filed: 2001-02-12
Granted: 2003-09-18
Abstract: The tanker vehicle tank has a cylindrical casing (1) closed at each end and having an access hatch (2) at the top. The hatch has a cylindrical shaft (21) and a cover (22). The shaft extends into the tank from the top (11) at a level such that the upper surface of the cover defines a plane (A) parallel to and at a small distance from the top. The shaft is enclosed by a flank (24) opening at a point on the tank.
Patent DE-60101065-D1 (DE)
Inventor: TRUMBLE SHAW
IPC: C09K11/08
Filed: 2001-01-10
Granted: 2003-12-04
Abstract: A luminescent nanophase binder is provided for use in UV and VUV applications. The binder promotes adherence of phosphor coatings to lamp envelopes and emits visible light under UV and VUV excitation. In a preferred embodiment, the binder comprises SiO2 nanoparticles doped with terbium or terbium and yttrium. Preferably, the nanoparticles have a particle size of less than 50 nm.
Patent DE-60101297-D1 (DE)
Inventor: CHANG JUNHUA
IPC: B41J2/01
Filed: 2001-09-07
Granted: 2004-01-08
Abstract: A driving signal generation unit (83) generates a plurality of kinds of driving pulses and a minute vibration pulse to be applied to a pressure generation element (25) so as to finely vibrate a meniscus of liquid. A pulse generation unit (72,73,74,75) generates the minute vibration pulse and the driving pulses by selecting a part of the driving signal. The driving signal includes a plurality of waveform elements used to generate the driving pulses and a connection element used to connect the waveform elements between different voltage levels and not used to generate the driving pulses. The pulse generation unit generates the minute vibration pulse by a combination of at least a part of the waveform elements and at least a part of the connection element. A plurality of driving pulses for ejecting a plurality of kinds of ink drops and a minute vibration pulse for causing minute vibrations to a meniscus of liquid can be efficiently put in a driving signal of one driving period. <IMAGE>
Patent DE-60101310-D1 (DE)
Inventor: AASTUEN J
IPC: G02B5/30
Filed: 2001-01-25
Granted: 2004-01-08
Abstract: An optical imaging system including an illumination system, a Cartesian PBS, and a prism assembly. The illumination system provides a beam of light, the illumination system having an f/# less than or equal to 2.5. The Cartesian polarizing beam splitter has a first tilt axis, oriented to receive the beam of light. A first polarized beam of light having one polarization direction is folded by the Cartesian polarizing beam splitter and a second polarized beam of light having a second polarization direction is transmitted by the Cartesian polarizing beam splitter. The Cartesian polarizing beam splitter nominally polarizes the beam of light with respect to the Cartesian beam splitter to yield the first polarized beam in the first polarization direction. The color separation and recombination prism is optically aligned to receive the first polarized beam. The prism has a second tilt axis, a plurality of color separating surfaces, and a plurality of exit surfaces. The second tilt axis may be oriented perpendicularly to the first tilt axis of the Cartesian polarizing beam splitter so that the polarized beam is nominally polarization rotated into the second polarization direction with respect to the color separating surfaces and a respective beam of colored light exits through each of the exit surfaces. Each imager is placed at one of the exit surface of the color separating and recombining prism to receive one of the respective beams of colored light, wherein each imager can separately modulate the polarization state of the beam of colored light.
Patent DE-60108285-D1 (DE)
Inventor: DEMARQUILLY FRANCIS
IPC: B60R21/233
Filed: 2001-03-02
Granted: 2005-02-17
Abstract: The inflatable cushion (1), fastened to the front of a vehicle (5) such as a tram and inflated by automatic or driver control, has a thrust surface (7) in contact with the vehicle and an impact surface (8) to receive a direct impact. It has a series of internal tie lines (2) made from non-stretch cords or straps between points (7a, 8a) on the inner surfaces of the thrust and impact surfaces.
Patent DE-60108630-D1 (DE)
Inventor: KELLY A
IPC: G01N33/52
Filed: 2001-06-04
Granted: 2005-03-03
Abstract: The present invention relates generally to self-contained devices and methods for detecting biological contaminants and, more particularly, to self-contained devices and methods for detecting biological contaminants in relevant settings including, for example, food processing plants, hospitals, medical offices, veterinary offices, and restaurants by using a device or methodology that includes a sampler component and dye component that binds to the biological material in a detectable fashion.
Patent DE-60115092-D1 (DE)
Inventor: BAKTHAVATCHALAM RAJAGOPAL
IPC: A61P43/00
Filed: 2001-12-11
Granted: 2005-12-22
Abstract: Substituted spiro[isobenzofuran-1,4'-piperidin]-3-ones and 3H-spiroisobenzofuran-1,4'-piperidines capable of modulating NPY5 receptor activity are provided. Such compounds may be used to modulate ligand binding to NPY5 receptors in vivo or in vitro, and are particularly useful in the treatment of a variety of disorders (e.g., eating disorders such as obesity or bulimia, psychiatric disorders, diabetes and cardiovascular disorders such as hypertension) in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and methods for treating such disorders are provided, as are methods for using such compounds for detecting NPY5 receptors.
Patent DE-60120621-D1 (DE)
Inventor: JACOBS ANTONIUS A C
IPC: A61K39/145
Filed: 2001-12-14
Granted: 2006-07-27
Abstract: The present invention relates i.a. to nucleic acid sequences encoding novel  Lawsonia intracellularis  proteins. It furthermore relates to DNA fragments, recombinant DNA molecules and live recombinant carriers comprising these sequences. Also it relates to host cells comprising such nucleic acid sequences, DNA fragments, recombinant DNA molecules and live recombinant carriers. Moreover, the invention relates to proteins encoded by these nucleotide sequences. The invention also relates to vaccines for combating  Lawsonia intracellularis  infections and methods for the preparation thereof. Finally the invention relates to diagnostic tests for the detection of  Lawsonia intracellularis  DNA, the detection of  Lawsonia intracellularis  antigens and of antibodies against  Lawsonia intracellularis.
Patent DE-60122444-D1 (DE)
Inventor: BATEMAN TIMOTHY
IPC: A61M16/04
Filed: 2001-08-23
Granted: 2006-10-05
Abstract: A ventilation device has a flexible adhesive sheet 1 that can be sealed around the patient's nose and mouth. A fitting 16 extending through the sheet in the region of the mouth enables the patient to be ventilated by means of a vent tube 17 inserted through the fitting. <IMAGE>
Patent DE-60123943-D1 (DE)
Inventor: CULLY F
IPC: G01N33/53
Filed: 2001-03-28
Granted: 2006-11-30
Abstract: The present invention relates in part to isolated nucleic acid molecules (polynucleotides) which encode  Dermacentor variabilis  ligand gated ion channel proteins. The present invention also relates to recombinant vectors and recombinant hosts which contain a DNA fragment encoding  D. variabilis  LGIC/GluCI channels, substantially purified forms of associated  D. variabilis  channel proteins and recombinant membrane fractions comprising these proteins, associated mutant proteins, and methods associated with identifying compounds which modulate associated  Dermacentor variabilis  LGIC/GluCI, which will be useful as insecticides and acaracides.
Patent DE-60128391-D1 (DE)
Inventor: CASTRO SALVATORE
IPC: A61F2/30
Filed: 2001-12-12
Granted: 2007-06-21
Abstract: The invention is a single piece, self seating and locking dynamic intervertebral spacer. The dynamic spacer is load-supporting but also able to undergo flexure in either or both the lateral and sagittal planes.
Patent DE-60128476-D1 (DE)
Inventor: OGAWA MIKIO
IPC: A61K31/4725
Filed: 2001-07-30
Granted: 2007-06-28
Abstract: A 3,4-dihydroisoquinoline derivative compound of formula (I) or a non-toxic salt thereof and a pharmaceutical agent comprising it as active ingredient (wherein all symbols have the same meaning as described in the specification). The compound of formula (I) has agonizing activity on CB2 receptor and therefore it is useful for the prophilaxis and/or treatment of various diseases such as asthma, nasal allergy, atopic dermatitis, autoimmune diseases, rheumatoid arthritis, immune dysfunction, postoperative pain, carcinomatous pain, etc. <CHEM>
Patent DE-60135649-D1 (DE)
Inventor: THOMPSON MICHAEL M
IPC: A01N59/14
Filed: 2001-06-06
Granted: 2008-10-16
Abstract: A wood preservative composition for protecting wood and wood products against water damage and/or insect damage, comprising a boron-containing material; and a silane.
Patent DE-60137215-D1 (DE)
Inventor: RHEE YOUNG WOO
IPC: G07F7/00
Filed: 2001-05-22
Granted: 2009-02-12
Abstract: This invention provides a new catalyst for purification of diesel engine exhaust gas comprising a carrier of at least one sulfur-resistant refractory oxide and at least one catalytic metal, wherein at least one solid acid or sulfuric acid is carried on the carrier by adding at least one precursor of said solid acid and/or sulfuric acid during the preparation of the carrier, and preparation thereof. The catalyst of this invention is thermally and chemically durable and can effectively remove particulate matters, hydrocarbons and nitrogen oxides contained in the diesel engine exhaust gas at low temperatures.
Patent DE-60140426-D1 (DE)
Inventor: SMEETS RUDOLF LEONARDUS
IPC: A23L33/15
Filed: 2001-02-12
Granted: 2009-12-24
Abstract: A pharmaceutical composition suitable for enhancing muscular anabolism contains, per daily dose, at least 5 mg of anabolic initiators comprising anabolic growth factors, at least 0.12 g of protein equivalents of anabolic substrates and at least 3 g of anabolic facilitators comprising at least 1 g of creatine or its functional analog. The anabolic initiators may be derived from a non-denatured animal protein, non-denatured being defined as having an F0 of less than 3.0.